Addressing the Challenges of Using Biocatalysis for Small Molecule Manufacture

October 13, 2021
8:00 a.m. PDT, 11:00 a.m. EDT, 16:00 BST, 17:00 CEST
Duration: 60 Minutes


When compared to traditional synthetic methodologies, the use of biocatalysis for the manufacture of small molecule active pharmaceutical ingredients is increasingly recognized as a more sustainable alternative. Biocatalysis often afford superior product quality, reduced energy needs, low environmental impacts, and access to novel transformations. Despite these promising attributes, biocatalysis is often not considered due to barrier of entry that hamper adoption early in the drug development lifecycle, such as enzyme access, high cost of development, and intellectual property constraints. 

In this webinar, we will discuss how these barriers are overcome at Asymchem by sharing some case studies where the benefits of biocatalysis were realized in real-world applications to support drug product development.  

Key Learning Objectives:

  • Benefits of biocatalytic small molecule manufacturing
  • Strategies for biocatalytic manufacturing

Who Should Attend:

  • Process chemists
  • Small molecule manufacturers
  • New small molecule product developers

Brought to you by:


Xuecheng Jiao, Ph.D.
Director, Center of Biosynthesis Technology,
Asymchem Group
Catherine Dold
Health & Environment Writer,
C&EN Media Group


*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

© 2021 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy